Data custodianship of connected devices, environmental impact and adherence technologies highlighted at Pharmapack Europe 2020

Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.

Paris, 19^th February 2020: Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are two of the latest key strategies aimed at reducing waste and protecting the bottom line, according to experts at the recent Pharmapack Europe (#pharmapackeu). The event is widely seen as an excellent yardstick of the industry’s prospects for the year ahead. Encouragingly, the event played host a record 411 exhibiting companies, 5366 attendees and 325 delegates.

Europe’s leading pharmaceutical packaging and drug delivery event – which took place at the Paris Expo, Porte de Versailles, February 5-6 – featured many innovations as well as novel drug delivery solutions, with ‘waste management’, “connectivity” and “patient centricity” being some the key themes throughout this year’s edition.

A who’s who of pharma packaging and drug device innovators exhibited from Aptar, SHL, Stevanato Group and BD to Nemera and West Pharmaceutical Services – with several major new technologies and partnerships announced. But some of the most promising innovations were presented by emerging companies in the Start-up hub – with technologies featured from AI development platforms through miniaturized/non-intrusive sensors, to vial/ampule combination devices ad smart packaging.

The conference played host to four themed content sessions, while the learning labs and several educational and interactive workshops explored major industry changes that lie ahead. Aurelio Arias, Engagement Manager at IQVIA suggested during his session that ‘the future of Value-Added Medicines is not just driven by deeper Insights and data capture but will also see gamification transforming engagement of therapies’. Arias added that ‘while patients are concerned about the security and the custodianship of their data’, they are still actively using connected devices. As a result, the natural evolution of this trend could be that healthcare companies will increasingly incentivise better compliance through gamification.

Yet one area that connected devices perhaps lag begin other areas of pharma packaging and devices is in environmental impact. Gregor Anderson, Managing Director at Pharmacentric solutions believes that the industry still has a long way to go when it comes to the sustainability of connected devices, commenting on ‘the duality of connected devices’. On one hand, it is an exciting field of new possibilities, but unfortunately on the other, we have not yet ‘fully married them with our sustainability goals’. He believes that is the next evolution for the industry in the year ahead, as more devices and technologies are now moving into commercial applications

In the ‘Challenges in drug delivery for biologics’ session, experts agreed that combining biologic drug and device development, while meeting regulatory standards is a significant learning curve for the industry. Overall, drug delivery was seen as increasingly integral to the growth of the biologics market, with patient centricity an essential component in adherence. In the short term, this is projected to push manufacturers to provide better devices – that ease the patient experience. But in the long term, experts postulated connected devices will play a major role in the advancement of the biologics industry – with increasingly levels of vital data on how devices are used post launch.

In the ‘New horizons in innovation’ session, Marc Rohrschneider, Head New Technologies, Device Development and Commercialisation at Novartis AG predicted that with pharma now having access to technology to connect boxes, vials and devices to networks, the next decade is not about the technology challenges. But will instead explore how the industry safeguards data, and ultimately, who is its custodian. Blockchain is another industry buzzword of the last year, but experts at Pharmapack point to the improved accountability it could provide in pharma supply as its most immediate use, rather than in securing patient data. “You should think of it as the most secure audit trail you can have. Immutable, temporal and despite what many have said, scalable” commented Jason Lacombe, Chief Executive Officer, Veratrak. But the key to delivering on its potential is for pharma and tech communities to work closer together to deliver over the hype.

Silvia Forroova, Brand Director at Pharmapack Europe commented, “In the last few years, as our Pharmapack agenda is testament to, we have seen the rise of truly patient centric delivery forms, increasingly smart and child safe packaging, and a growing awareness of the vital role we can play in bringing about a more environmentally friendly industry. But what we are also seeing is that by bringing different groups together we are reinventing the art of the possible. It’s one of the greatest strengths of Pharmapack that we provide a platform to help build networks and communities, share learning and celebrate new innovations. Our experience of this event in 2020 is that the industry looks well set for growth in the year ahead and we can expect to see more collaborations in an age when the delivery of products is changing quickly. This is great news for drug delivery and packaging companies, but even better news for patients.”

Pharmapack Europe 2021 return to the Paris Expo, Porte De Versailles in Paris between the 27 & 28 January and is the leading hub for stakeholders across all parts of the pharmaceutical packaging and drug delivery supply chain.

To exhibit at next year’s show, please visit: https://www.pharmapackeurope.com/en/exhibit/book-your-stand.html

-ENDS-

Notes to Editors

Or for more information on the event and conference, please visit: https://www.pharmapackeurope.com/

About Pharmapack

Launched in 1997, Pharmapack is the European event for Pharmaceutical Packaging, Drug Delivery, Medical Devices and Machinery. Pharmapack started as a biennial conference and exhibition, taking place every other year in Paris, until industry developments demanded a more frequent event to help the industry stay up to date on the latest trends, developments and regulations. In the past 20+ years, the event has grown from a conference with a small table-top exhibition, to an event hosting 411 exhibitors and welcoming 5,290 attendees over 2 days. In 2018, Pharmapack also featured the International Meetings Programme (business matching), an International Meetings Programme, full 2-day Conference, 1-day Symposium, Workshops, Learning Lab presentations, Awards ceremonies, a Start-up Hub, Innovation Gallery and Tours.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit www.informamarkets.com.

The Informa Markets annual schedule of Pharmaceutical eventsnclude: CPhI Japan (16-18 March, 2020 at the Big Sight Exhibition Centre – Tokyo, Japan); CPhI North America (05 April - 07 May, 2020 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI and P-MEC China (22-24 June, 2020 at SNIEC – Shanghai, China); CPhI South East Asia (1-3 July, 2020 at the IMPACT Centre – Bangkok, Thailand); CPhI Korea (26-28 August 2020), COEX – Seoul, Korea); CPhI Middle East & Africa (14-16 September, 2020 at the ADNEC – Abu Dhabi, United Arab Emirates); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (13-15 October, 2020 at Fiera Milano, Milan)

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.com / a.khalifeh@defacto.com